In vitro, in vivo and microscopic analysis of tumor immunotherapy using combination of two antibodies against the same ErbB2 target

Eitemau Tebyg

• The combination of trastuzumab and pertuzumab administered at approved doses may delay development of trastuzumab resistance by additively enhancing antibody-dependent cell-mediated cytotoxicity
  gan: Tóth, Gábor, et al.
  Cyhoeddwyd: (2016)
• Molecular Modeling of Nearly Full-Length ErbB2 Receptor
  gan: Bagossi, Péter, et al.
  Cyhoeddwyd: (2005)
• A Small Number of HER2 Redirected CAR T Cells Significantly Improves Immune Response of Adoptively Transferred Mouse Lymphocytes against Human Breast Cancer Xenografts
  gan: Tóth, Gábor, et al.
  Cyhoeddwyd: (2020)
• Quantitative Characterization of the Large-Scale Association of ErbB1 and ErbB2 by Flow Cytometric Homo-FRET Measurements
  gan: Szabó, Ágnes, et al.
  Cyhoeddwyd: (2008)
• Coclustering of ErbB1 and ErbB2 Revealed by FRET-Sensitized Acceptor Bleaching
  gan: Szabó, Ágnes, et al.
  Cyhoeddwyd: (2010)